Report Detail

Request for Sample of this report

Pharma & Healthcare Global Covid-19 Vaccine Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4529158
    • |
  • 13 April, 2023
    • |
  • Global
    • |
  • 89 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

A COVID-19 vaccine is a hypothetical vaccine against coronavirus disease 2019 (COVID-19). Although no vaccine has completed clinical trials, there are multiple attempts in progress to develop such a vaccine.
The genetic sequence of SARS-CoV-2, the coronavirus that causes COVID-19, was published on 11 January 2020, triggering intense global R&D activity to develop a vaccine against the disease. The scale of the humanitarian and economic impact of the COVID-19 pandemic is driving evaluation of next-generation vaccine technology platforms through novel paradigms to accelerate development, and the first COVID-19 vaccine candidate entered human clinical testing with unprecedented rapidity on 16 March 2020.

The global vaccine R&D effort in response to the COVID-19 pandemic is unprecedented in terms of scale and speed. Given the imperative for speed, there is an indication that vaccine could be available under emergency use or similar protocols by early 2021. This would represent a fundamental step change from the traditional vaccine development pathway, which takes on average over 10 years, even compared with the accelerated 5-year timescale for development of the first Ebola vaccine, and will necessitate novel vaccine development paradigms involving parallel and adaptive development phases, innovative regulatory processes and scaling manufacturing capacity.
According to our (Global Info Research) latest study, the global Covid-19 Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest consumption place, with a consumption market share nearly 53.8% in 2026, Europe is the second largest consumption place with the consumption market share of 24.61% in 2026.
This report is a detailed and comprehensive analysis for global Covid-19 Vaccine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Covid-19 Vaccine market size and forecasts, in consumption value ($ Million), 2018-2029
Global Covid-19 Vaccine market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Covid-19 Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Covid-19 Vaccine market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Covid-19 Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Covid-19 Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna, CanSino Biologicals, Inovio Pharmaceuticals, Shenzhen Geno-Immune Medical Institute and GlaxoSmithKine, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Covid-19 Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
DNA
Non-replicating Viral Vector
Protein Subunit
RNA
Others
Market segment by Application
Adults
Children
Market segment by players, this report covers
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson＆Johnson
Heat Biologics
Sanofi
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Covid-19 Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Covid-19 Vaccine, with revenue, gross margin and global market share of Covid-19 Vaccine from 2018 to 2023.
Chapter 3, the Covid-19 Vaccine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Covid-19 Vaccine market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Covid-19 Vaccine.
Chapter 13, to describe Covid-19 Vaccine research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Covid-19 Vaccine
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Covid-19 Vaccine by Type
    • 1.3.1 Overview: Global Covid-19 Vaccine Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Covid-19 Vaccine Consumption Value Market Share by Type in 2022
    • 1.3.3 DNA
    • 1.3.4 Non-replicating Viral Vector
    • 1.3.5 Protein Subunit
    • 1.3.6 RNA
    • 1.3.7 Others
  • 1.4 Global Covid-19 Vaccine Market by Application
    • 1.4.1 Overview: Global Covid-19 Vaccine Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Adults
    • 1.4.3 Children
  • 1.5 Global Covid-19 Vaccine Market Size & Forecast
  • 1.6 Global Covid-19 Vaccine Market Size and Forecast by Region
    • 1.6.1 Global Covid-19 Vaccine Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Covid-19 Vaccine Market Size by Region, (2018-2029)
    • 1.6.3 North America Covid-19 Vaccine Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Covid-19 Vaccine Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Covid-19 Vaccine Market Size and Prospect (2018-2029)
    • 1.6.6 South America Covid-19 Vaccine Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Covid-19 Vaccine Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Moderna
    • 2.1.1 Moderna Details
    • 2.1.2 Moderna Major Business
    • 2.1.3 Moderna Covid-19 Vaccine Product and Solutions
    • 2.1.4 Moderna Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Moderna Recent Developments and Future Plans
  • 2.2 CanSino Biologicals
    • 2.2.1 CanSino Biologicals Details
    • 2.2.2 CanSino Biologicals Major Business
    • 2.2.3 CanSino Biologicals Covid-19 Vaccine Product and Solutions
    • 2.2.4 CanSino Biologicals Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 CanSino Biologicals Recent Developments and Future Plans
  • 2.3 Inovio Pharmaceuticals
    • 2.3.1 Inovio Pharmaceuticals Details
    • 2.3.2 Inovio Pharmaceuticals Major Business
    • 2.3.3 Inovio Pharmaceuticals Covid-19 Vaccine Product and Solutions
    • 2.3.4 Inovio Pharmaceuticals Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Inovio Pharmaceuticals Recent Developments and Future Plans
  • 2.4 Shenzhen Geno-Immune Medical Institute
    • 2.4.1 Shenzhen Geno-Immune Medical Institute Details
    • 2.4.2 Shenzhen Geno-Immune Medical Institute Major Business
    • 2.4.3 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Product and Solutions
    • 2.4.4 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Shenzhen Geno-Immune Medical Institute Recent Developments and Future Plans
  • 2.5 GlaxoSmithKine
    • 2.5.1 GlaxoSmithKine Details
    • 2.5.2 GlaxoSmithKine Major Business
    • 2.5.3 GlaxoSmithKine Covid-19 Vaccine Product and Solutions
    • 2.5.4 GlaxoSmithKine Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 GlaxoSmithKine Recent Developments and Future Plans
  • 2.6 Pfizer
    • 2.6.1 Pfizer Details
    • 2.6.2 Pfizer Major Business
    • 2.6.3 Pfizer Covid-19 Vaccine Product and Solutions
    • 2.6.4 Pfizer Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Pfizer Recent Developments and Future Plans
  • 2.7 Johnson＆Johnson
    • 2.7.1 Johnson＆Johnson Details
    • 2.7.2 Johnson＆Johnson Major Business
    • 2.7.3 Johnson＆Johnson Covid-19 Vaccine Product and Solutions
    • 2.7.4 Johnson＆Johnson Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Johnson＆Johnson Recent Developments and Future Plans
  • 2.8 Heat Biologics
    • 2.8.1 Heat Biologics Details
    • 2.8.2 Heat Biologics Major Business
    • 2.8.3 Heat Biologics Covid-19 Vaccine Product and Solutions
    • 2.8.4 Heat Biologics Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Heat Biologics Recent Developments and Future Plans
  • 2.9 Sanofi
    • 2.9.1 Sanofi Details
    • 2.9.2 Sanofi Major Business
    • 2.9.3 Sanofi Covid-19 Vaccine Product and Solutions
    • 2.9.4 Sanofi Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Sanofi Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Covid-19 Vaccine Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Covid-19 Vaccine by Company Revenue
    • 3.2.2 Top 3 Covid-19 Vaccine Players Market Share in 2022
    • 3.2.3 Top 6 Covid-19 Vaccine Players Market Share in 2022
  • 3.3 Covid-19 Vaccine Market: Overall Company Footprint Analysis
    • 3.3.1 Covid-19 Vaccine Market: Region Footprint
    • 3.3.2 Covid-19 Vaccine Market: Company Product Type Footprint
    • 3.3.3 Covid-19 Vaccine Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Covid-19 Vaccine Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Covid-19 Vaccine Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Covid-19 Vaccine Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Covid-19 Vaccine Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Covid-19 Vaccine Consumption Value by Type (2018-2029)
  • 6.2 North America Covid-19 Vaccine Consumption Value by Application (2018-2029)
  • 6.3 North America Covid-19 Vaccine Market Size by Country
    • 6.3.1 North America Covid-19 Vaccine Consumption Value by Country (2018-2029)
    • 6.3.2 United States Covid-19 Vaccine Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Covid-19 Vaccine Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Covid-19 Vaccine Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Covid-19 Vaccine Consumption Value by Type (2018-2029)
  • 7.2 Europe Covid-19 Vaccine Consumption Value by Application (2018-2029)
  • 7.3 Europe Covid-19 Vaccine Market Size by Country
    • 7.3.1 Europe Covid-19 Vaccine Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Covid-19 Vaccine Market Size and Forecast (2018-2029)
    • 7.3.3 France Covid-19 Vaccine Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Covid-19 Vaccine Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Covid-19 Vaccine Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Covid-19 Vaccine Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Covid-19 Vaccine Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Covid-19 Vaccine Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Covid-19 Vaccine Market Size by Region
    • 8.3.1 Asia-Pacific Covid-19 Vaccine Consumption Value by Region (2018-2029)
    • 8.3.2 China Covid-19 Vaccine Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Covid-19 Vaccine Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Covid-19 Vaccine Market Size and Forecast (2018-2029)
    • 8.3.5 India Covid-19 Vaccine Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Covid-19 Vaccine Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Covid-19 Vaccine Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Covid-19 Vaccine Consumption Value by Type (2018-2029)
  • 9.2 South America Covid-19 Vaccine Consumption Value by Application (2018-2029)
  • 9.3 South America Covid-19 Vaccine Market Size by Country
    • 9.3.1 South America Covid-19 Vaccine Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Covid-19 Vaccine Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Covid-19 Vaccine Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Covid-19 Vaccine Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Covid-19 Vaccine Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Covid-19 Vaccine Market Size by Country
    • 10.3.1 Middle East & Africa Covid-19 Vaccine Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Covid-19 Vaccine Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Covid-19 Vaccine Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Covid-19 Vaccine Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Covid-19 Vaccine Market Drivers
  • 11.2 Covid-19 Vaccine Market Restraints
  • 11.3 Covid-19 Vaccine Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Covid-19 Vaccine Industry Chain
  • 12.2 Covid-19 Vaccine Upstream Analysis
  • 12.3 Covid-19 Vaccine Midstream Analysis
  • 12.4 Covid-19 Vaccine Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Covid-19 Vaccine. Industry analysis & Market Report on Covid-19 Vaccine is a syndicated market report, published as Global Covid-19 Vaccine Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Covid-19 Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,773.56
    		4,160.34
    		5,547.12
    		3,236.40
    		4,854.60
    		6,472.80
    		532,022.40
    		798,033.60
    		1,064,044.80
    		290,336.40
    		435,504.60
    		580,672.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo